<DOC>
	<DOCNO>NCT00272337</DOCNO>
	<brief_summary>The purpose study test high versus lower dose aspirin marker atherosclerosis patient heart attack .</brief_summary>
	<brief_title>Aspirin Dose Atherosclerosis Patients With Heart Disease</brief_title>
	<detailed_description>Aspirin reduce risk heart attack , stroke , death cardiovascular cause patient survive prior event well acute heart attack . Low dose aspirin sufficient achieve complete inhibition platelet aggregability , stickiness , mechanism whereby aspirin prevent formation blood clot . Our research design explore whether high dos aspirin provide additional benefit marker atherosclerosis .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>1 . Age 40 80 year , inclusive . 2 . Patients stable coronary disease , without diabetes mellitus , define : 1. angiographic evidence 70 % great stenosis , 2. previous percutaneous coronary intervention ( PCI ) , 3. coronary artery bypass graft ( CABG ) , 4. history MI , 5. positive exercise test 1 . Patients take great 81mg aspirin daily . 2 . Patients take follow medication less 3 month , plan take first time next 3 month : ACEinhibitors , angiotensin receptor blocker , calcium channel blocker , statin . 3 . Patients within 6 month coronary intervention , include PCI CABG . 4 . Patients plan coronary intervention . 5 . Patients take antiplatelet drug clopidogrel nonsteroidal antiinflammatory drug ( NSAIDs ) anticoagulant drug warfarin . 6 . Patients currently cigarette smoker . 7 . Women patient pregnant , plan become pregnant , nursing child , take hormone replacement therapy . 8 . Patients coagulation , bleed blood disorder . 9 . Patients sensitive allergic aspirin . 10 . Patients document history gastrointestinal disorder , include bleed ulcer . 11 . Patients evidence cancer kidney , liver , lung , blood , brain disorder . 12 . Patients asthma , rhinitis , nasal polyp . 13 . Patients abnormal laboratory value physical finding , view responsible clinician , may interfere interpretation trial result , indicative underlying disease state , compromise safety . 14 . Patients Class IV heart failure . 15 . Patients severe aortic insufficiency , aortic regurgitation . 16 . Patients hear loss tinnitus . 17 . Patients tremor cause able remain motionless approximately 30 second .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Cardiovascular disease</keyword>
	<keyword>Aspirin</keyword>
	<keyword>Atherosclerosis</keyword>
	<keyword>Myocardial Infarction</keyword>
</DOC>